Related Experiment Video
Updated: Mar 3, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes
1Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Tumor Microenvironment Global Core Research Center, Medicinal Bioconvergence Research Center, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Abstract:
Transmembrane 4 L six family member 5 (TM4SF5) can form tetraspanin-enriched microdomains (TERMs) on the cell's surface. TERMs contain protein-protein complexes comprised of tetraspanins, growth factor receptors, and integrins. These complexes regulate communication between extracellular and intracellular spaces to control diverse cellular functions. TM4SF5 influences the epithelial-mesenchymal transition (EMT), aberrant multilayer cellular growth, drug resistance, enhanced migration and invasion, circulation through the bloodstream, tumor-initiation property, metastasis, and muscle development in zebrafish. Here, current data on TM4SF5's roles in the development of fibrotic phenotypes are reviewed. TM4SF5 is induced by transforming growth factor β1 (TGFβ1) signaling via a collaboration with epidermal growth factor receptor (EGFR) activation. TM4SF5, by itself or in concert with other receptors, transduces signals intracellularly. In hepatocytes, TM4SF5 expression regulates cell cycle progression, migration, and expression of extracellular matrix components. In CCl4-treated mice, TM4SF5, α-smooth muscle actin (α-SMA), and collagen I expression are observed together along the fibrotic septa regions of the liver. These fibrotic phenotypes are diminished by anti-TM4SF5 reagents, such as a specific small compound [TSAHC, 4'-(p-toluenesulfonylamido)-4-hydroxychalcone] or a chimeric antibody. This review discusses the antifibrotic strategies that target TM4SF5 and its associated protein networks that regulate the intracellular signaling necessary for fibrotic functions of hepatocytes.
Insights
Transmembrane 4 L six family member 5 (TM4SF5) drives liver fibrosis by regulating cell growth and extracellular matrix. Targeting TM4SF5 with specific compounds or antibodies shows promise in reducing fibrotic phenotypes.
Area of Science:
- Molecular Biology
- Cell Biology
- Hepatology
Background:
- Transmembrane 4 L six family member 5 (TM4SF5) forms tetraspanin-enriched microdomains (TERMs) on cell surfaces.
- TERMs regulate intercellular communication and control diverse cellular functions, including epithelial-mesenchymal transition (EMT) and metastasis.
- TM4SF5 is implicated in various cellular processes, including aberrant growth, drug resistance, and migration.
Purpose of the Study:
- To review current data on the role of TM4SF5 in the development of fibrotic phenotypes.
- To discuss the molecular mechanisms by which TM4SF5 contributes to liver fibrosis.
- To explore antifibrotic strategies targeting TM4SF5 and its associated signaling networks.
Main Methods:
- Review of existing literature on TM4SF5 and fibrotic phenotypes.
- Analysis of TM4SF5 induction by transforming growth factor β1 (TGFβ1) and epidermal growth factor receptor (EGFR) signaling.
- Investigation of TM4SF5's role in hepatocyte cell cycle, migration, and extracellular matrix production.
- Examination of TM4SF5, α-smooth muscle actin (α-SMA), and collagen I expression in CCl4-treated mice.
Main Results:
- TM4SF5 expression is induced by TGFβ1 and EGFR activation.
- In hepatocytes, TM4SF5 regulates cell cycle, migration, and extracellular matrix component expression.
- TM4SF5, α-SMA, and collagen I are co-expressed in fibrotic liver septa of CCl4-treated mice.
- Antifibrotic reagents targeting TM4SF5 diminish fibrotic phenotypes.
Conclusions:
- TM4SF5 plays a significant role in the development of liver fibrosis.
- Targeting TM4SF5 and its associated protein networks offers a potential therapeutic strategy for liver fibrosis.
- Specific small compounds and chimeric antibodies against TM4SF5 demonstrate antifibrotic effects.
More Related Videos
Related Concept Videos
Introduction to Fibroblasts
TGF - β Signaling Pathway

